Clinical trial
Efficacy of Riluzole in Patients With Cervical Spondylotic Myelopathy Undergoing Surgical Treatment. A Randomized, Double-Blind, Placebo-controlled Multi-Center Study
NCT01257828 is registered in ClinicalTrials.gov with AOSpine North America Research Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Riluzole in Patients With Cervical Spondylotic Myelopathy Undergoing Surgical Treatment. A Randomized, Double-Blind, Placebo-controlled Multi-Center Study
- Lead sponsor
- AOSpine North America Research Network
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- June 1, 2018
- Enrollment
- 270 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.
cervical spondylotic myelopathy